MARC details
| 000 -LEADER |
| fixed length control field |
03089 a2200409 4500 |
| 001 - CONTROL NUMBER |
| control field |
26002 |
| 003 - CONTROL NUMBER IDENTIFIER |
| control field |
TR-AnTOB |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
| control field |
20240927104042.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
| fixed length control field |
161010bs2006 tu ka b 000 0 |
| 015 ## - NATIONAL BIBLIOGRAPHY NUMBER |
| National bibliography number |
GBA601442 |
| Source |
bnb |
| 016 ## - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER |
| Record control number |
013348527 |
| Source |
Uk |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
0521858224 (hbk.) |
| 024 ## - OTHER STANDARD IDENTIFIER |
| Standard number or code |
9780521858229 (hbk.) |
| 035 ## - SYSTEM CONTROL NUMBER |
| System control number |
(OCoLC)OCM62475370 |
| 040 ## - CATALOGING SOURCE |
| Original cataloging agency |
UKM |
| Transcribing agency |
UKM |
| Modifying agency |
BAKER |
| -- |
BWKUK |
| -- |
OrLoB-B |
| -- |
TR-AnTOB |
| 041 ## - LANGUAGE CODE |
| Language code of text/sound track or separate title |
İngilizce |
| 060 ## - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
| Classification number |
QV 736 |
| Item number |
K73 2006 |
| 096 ## - LOCALLY ASSIGNED NLM-TYPE CALL NUMBER (OCLC) |
| Classification number |
QV736 K73 2006 |
| 245 00 - TITLE STATEMENT |
| Title |
Knowledge accumulation and industry evolution : |
| Remainder of title |
the case of Pharma-Biotech / |
| Statement of responsibility, etc. |
edited by Mariana Mazzucato and Giovanni Dosi. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
| Place of production, publication, distribution, manufacture |
Cambridge, UK ; |
| -- |
New York : |
| Name of producer, publisher, distributor, manufacturer |
Cambridge University Press, |
| Date of production, publication, distribution, manufacture, or copyright notice |
2006. |
| 300 ## - PHYSICAL DESCRIPTION |
| Extent |
xvii, 446 p. : |
| Other physical details |
ill. ; |
| Dimensions |
24 cm. |
| 336 ## - CONTENT TYPE |
| Source |
rdacontent |
| Content type term |
text |
| Content type code |
txt |
| 337 ## - MEDIA TYPE |
| Source |
rdamedia |
| Media type term |
unmediated |
| Media type code |
n |
| 338 ## - CARRIER TYPE |
| Source |
rdacarrier |
| Carrier type term |
volume |
| Carrier type code |
nc |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
| Bibliography, etc. note |
|
| 505 #0 - FORMATTED CONTENTS NOTE |
| Miscellaneous information |
1. |
| -- |
2. |
| -- |
3. |
| -- |
4. |
| -- |
5. |
| -- |
6. |
| -- |
7. |
| -- |
8. |
| -- |
9. |
| -- |
10. |
| -- |
11. |
| -- |
12. |
| -- |
13. |
| -- |
14. |
| Statement of responsibility |
Giovanni Dosi and Mariana Mazzucato -- |
| -- |
Frank R. Lichtenberg -- |
| -- |
Paul Nightingale and Surya Mahdi -- |
| -- |
Myriam Mariani -- |
| -- |
Louis Galambos -- |
| -- |
Elena Cefis, Matteo Ciccarelli and Luigi Orsenigo -- |
| -- |
Giulio Bottazzi, Fabio Pammolli and Angelo Secchi -- |
| -- |
Christian Garavaglia, Franco Malerba and Luigi Orsenigo -- |
| -- |
Boyan Jovanovic -- |
| -- |
John P. Walsh, Ashish Arora and Wesley M. Cohen -- |
| -- |
Fabienne Orsi, Christine Sevilla and Benjamin Coriat -- |
| -- |
Pierre Regibeau and Katharine Rockett -- |
| -- |
Joyce Tait, Joanna Chataway, Catherine Lyall and David Wield -- |
| -- |
Luigi Orsenigo, Giovanni Dosi and Mariana Mazzucato. |
| Title |
Introduction / |
| -- |
Pharmaceutical innovation as a process of creative destruction / |
| -- |
The evolution of pharmaceutical innovation / |
| -- |
Firm and regional determinants in innovation models : evidence from biotechnology and traditional chemicals / |
| -- |
Innovation and industry evolution : a comment / |
| -- |
Heterogeneity and firm growth in the pharmaceutical industry / |
| -- |
Growth and diversification patterns of the worldwide pharmaceutical industry / |
| -- |
Entry, market structure, and innovation in a "history-friendly" model of the evolution of the pharmaceutical industry / |
| -- |
The growth of pharmaceutical firms : a comment / |
| -- |
The effects of research tool patents and licensing on biomedical innovation / |
| -- |
Upstream patents and public health : the case of genetic testing for breast cancer / |
| -- |
Competition, regulation, and intellectual property management in genetically modified foods : evidence from survey data / |
| -- |
Governance, policy, and industry strategies : pharmaceuticals and agro-biotechnology / |
| -- |
The dynamics of knowledge accumulation, regulation, and appropriability in the pharma-biotech sector : policy issues / |
| 650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name entry element |
Drug Industry |
| 9 (RLIN) |
23084 |
|
| Topical term or geographic name entry element |
Biomedical Research |
| 9 (RLIN) |
128330 |
|
| Topical term or geographic name entry element |
Biomedical Technology |
| 9 (RLIN) |
128329 |
|
| Topical term or geographic name entry element |
Technology, Pharmaceutical |
| 9 (RLIN) |
23088 |
|
| Topical term or geographic name entry element |
Economics, Pharmaceutical |
| 9 (RLIN) |
23086 |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
| Personal name |
Mazzucato, Mariana, |
| Dates associated with a name |
1968- |
| 9 (RLIN) |
23082 |
|
| Personal name |
Dosi, Giovanni |
| 9 (RLIN) |
23083 |
| 902 ## - LOCAL DATA ELEMENT B, LDB (RLIN) |
| a |
0014629 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
| Koha item type |
Book |
| Source of classification or shelving scheme |
National Library of Medicine |